Drug – bio-affecting and body treating compositions – In vivo diagnostic or in vivo test agent which contains an...
Patent
1990-11-30
1992-02-25
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
In vivo diagnostic or in vivo test agent which contains an...
514592, 514708, 514936, 514568, 514575, 514 2, A61K 3750
Patent
active
050911805
ABSTRACT:
The present invention is directed to the in vivo use of compounds which prevent the generation of, effectively scavenge, or detoxify a reactive oxygen metabolite that mediates a toxic effect of rhabdomyolysis and myoglobinuria. The compounds of the invention can be used to prevent or reduce rhabdomyolysis-induced renal damage, and include but are not limited to free radical scavengers, iron chelators, oxidizable compounds, enzymes which metabolize reactive oxygen metabolites or their precursors, and biosynthetic precursors thereof.
REFERENCES:
Baud et al. Am. J. Physiol. 251: F765-F776.
Shah Sudhir V.
Walker Patrick D.
Administrators of the Tulane Educational Fund
Robinson Douglas W.
Witz Jean C.
LandOfFree
Protection against rhabdomyolysis-induced nephrotoxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protection against rhabdomyolysis-induced nephrotoxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protection against rhabdomyolysis-induced nephrotoxicity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1891516